$CNSY 3 SEC Filings

Filed On	Filing
21 Apr 2026	Form 3: Daniels Eric Joseph, Chief Development Officer Holds 0 shares of Common Stock
30 Mar 2026	Form 3: Andrews Ronald Asbury, Director Holds 0 shares of Common Stock
15 Aug 2025	Form 3: Guse Kyle, Director Holds 0 shares of Common Stock
24 Nov 2021	Form 3: LaFrance Norman D., CHIEF MEDICAL OFFICER No securities owned
02 Apr 2020	Form 3: Lenk Robert P, Director No securities owned
02 Apr 2020	Form 3: Clowes Howard, Director No securities owned
14 Feb 2020	Form 3: Petersen Greg, Director No securities owned
10 Feb 2020	Form 3: Sims Andrew John Hugh MacIntyre, Chief Financial Officer No securities owned
02 Jan 2020	Form 3: van Es-Johansson An, Director No securities owned
01 Feb 2018	Form 3: PostFinance Ag, 10% owner Holds 5,540,054 shares of Common Stock
08 Jan 2018	Form 3: Swissquote Bank Sa, 10% owner Holds 5,540,055 shares of Common Stock
03 Apr 2017	Form 3: Lapointe Anthony Gregg, Director No securities owned
03 Jan 2017	Form 3: Martell Ron, Director No securities owned
22 Aug 2016	Form 3: Marino Mark, Chief Medical Officer
15 Oct 2015	Form 3: Harris John David, VP and GM of Cell Therapy No securities owned
19 Aug 2015	Form 3: Kesten Steven, Exec VP and Chief MO Holds 2,201 shares of Common Stock
12 Aug 2015	Form 3: Hayden Jeremy B., General Counsel & VP of BD No securities owned
04 Sep 2014	Form 3: Girao Tiago, VP & Chief Financial Officer No securities owned
02 Jul 2014	Form 3: Naughton Gail K, Director No securities owned
12 Jun 2014	Form 3: Jona Ruud J.p., Director No securities owned

Comments